1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- 3M
- Acelity LP Inc.
- ConvaTec Group Plc
- Mölnlycke Health Care AB
- Smith & Nephew Plc.
- MORE
About this market
Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio. Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period. The analysts have predicted that the radiodermatitis treatment market will register a CAGR of over 4% by 2023.
Market Overview
The rising number of public and private healthcare organizations
Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.
Advent of novel radiation equipment with fewer side-effects
The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.
For the detailed list of factors that will drive and challenge the growth of the radiodermatitis treatment market during 2019-2023, view the full report.
Competitive Landscape
The market appears to be moderately fragmented with the presence of several market players. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio. Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period. The analysts have predicted that the radiodermatitis treatment market will register a CAGR of over 4% by 2023.
Market Overview
The rising number of public and private healthcare organizations
Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.
Advent of novel radiation equipment with fewer side-effects
The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.
For the detailed list of factors that will drive and challenge the growth of the radiodermatitis treatment market during 2019-2023, view the full report.
Competitive Landscape
The market appears to be moderately fragmented with the presence of several market players. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- 3M
- Acelity LP Inc.
- ConvaTec Group Plc
- Mölnlycke Health Care AB
- Smith & Nephew Plc.
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 06: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY PRODUCT
PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
PART 11: GEOGRAPHIC LANDSCAPE
PART 13: DRIVERS AND CHALLENGES
PART 15: VENDOR LANDSCAPE
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Factors driving global radiodermatitis treatment market 2019-2023
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Types of radiodermatitis
Exhibit 11: Epidemiology statistics of cancer in the US
Exhibit 12: Five forces analysis 2018
Exhibit 13: Five forces analysis 2023
Exhibit 14: Bargaining power of buyers
Exhibit 15: Bargaining power of suppliers
Exhibit 16: Threat of new entrants
Exhibit 17: Threat of substitutes
Exhibit 18: Threat of rivalry
Exhibit 19: Market condition - Five forces 2018
Exhibit 20: Pipeline landscape
Exhibit 21: Some of the drugs investigated for radiodermatitis
Exhibit 22: Product - Market share 2018-2023 (%)
Exhibit 23: Comparison by product
Exhibit 24: Topical - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Topical - Year-over-year growth 2019-2023 (%)
Exhibit 26: Dressings - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Dressings - Year-over-year growth 2019-2023 (%)
Exhibit 28: Oral - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Oral - Year-over-year growth 2019-2023 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Market share by distribution channel, 2018
Exhibit 33: Market share by geography 2018-2023 (%)
Exhibit 34: Geographic comparison
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Incidence rate of lung cancer
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Key industry trends in North America
Exhibit 41: North America - Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in North America
Exhibit 43: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 44: Incidence rate of cancer in Germany, 2012
Exhibit 45: Projected incidence rate of cancer in Germany, 2030
Exhibit 46: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 47: Top 3 countries in Europe
Exhibit 48: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 49: Facts about cancer in Australia
Exhibit 50: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 51: Top 3 countries in ROW
Exhibit 52: Key leading countries
Exhibit 53: Market opportunity
Exhibit 54: Cancer prevalence in US in 2015
Exhibit 55: Cancer prevalence in England in 2016
Exhibit 56: Types of external beam radiation therapy
Exhibit 57: Impact of drivers and challenges
Exhibit 58: CDC statistics for obesity and diabetes
Exhibit 59: Vendor landscape
Exhibit 60: Landscape disruption
Exhibit 61: Vendors covered
Exhibit 62: Vendor classification
Exhibit 63: Market positioning of vendors
Exhibit 64: M - Vendor overview
Exhibit 65: M - Business segments
Exhibit 66: M - Organizational developments
Exhibit 67: M - Geographic focus
Exhibit 68: M - Segment focus
Exhibit 69: M - Key offerings
Exhibit 70: M - Key customers
Exhibit 71: Acelity LP Inc. - Vendor overview
Exhibit 72: Acelity LP Inc. - Organizational developments
Exhibit 73: Acelity LP Inc. - Key offerings
Exhibit 74: Acelity LP Inc. - Key customers
Exhibit 75: ConvaTec Group Plc - Vendor overview
Exhibit 76: ConvaTec Group Plc - Product segments
Exhibit 77: ConvaTec Group Plc - Organizational developments
Exhibit 78: ConvaTec Group Plc - Geographic focus
Exhibit 79: ConvaTec Group Plc - Segment focus
Exhibit 80: ConvaTec Group Plc - Key offerings
Exhibit 81: ConvaTec Group Plc - Key customers
Exhibit 82: Mölnlycke Health Care AB - Vendor overview
Exhibit 83: Mölnlycke Health Care AB - Product segments
Exhibit 84: Mölnlycke Health Care AB - Organizational developments
Exhibit 85: Mölnlycke Health Care AB - Geographic focus
Exhibit 86: Mölnlycke Health Care AB - Segment focus
Exhibit 87: Mölnlycke Health Care AB - Key offerings
Exhibit 88: Mölnlycke Health Care AB - Key customers
Exhibit 89: Smith & Nephew Plc - Vendor overview
Exhibit 90: Smith & Nephew Plc - Business segments
Exhibit 91: Smith & Nephew Plc - Organizational developments
Exhibit 92: Smith & Nephew Plc - Geographic focus
Exhibit 93: Smith & Nephew Plc - Segment focus
Exhibit 94: Smith & Nephew Plc - Key offerings
Exhibit 95: Smith & Nephew Plc - Key customers
Exhibit 96: Validation techniques employed for market sizing
Exhibit 97: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Topical - Market size and forecast 2018-2023
- Dressings - Market size and forecast 2018-2023
- Oral - Market size and forecast 2018-2023
- Market opportunity by product
PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
PART 11: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Asia - Market size and forecast 2018-2023
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 13: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 15: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- 3M
- Acelity LP Inc.
- ConvaTec Group Plc
- Mölnlycke Health Care AB
- Smith & Nephew Plc
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Factors driving global radiodermatitis treatment market 2019-2023
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Types of radiodermatitis
Exhibit 11: Epidemiology statistics of cancer in the US
Exhibit 12: Five forces analysis 2018
Exhibit 13: Five forces analysis 2023
Exhibit 14: Bargaining power of buyers
Exhibit 15: Bargaining power of suppliers
Exhibit 16: Threat of new entrants
Exhibit 17: Threat of substitutes
Exhibit 18: Threat of rivalry
Exhibit 19: Market condition - Five forces 2018
Exhibit 20: Pipeline landscape
Exhibit 21: Some of the drugs investigated for radiodermatitis
Exhibit 22: Product - Market share 2018-2023 (%)
Exhibit 23: Comparison by product
Exhibit 24: Topical - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Topical - Year-over-year growth 2019-2023 (%)
Exhibit 26: Dressings - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Dressings - Year-over-year growth 2019-2023 (%)
Exhibit 28: Oral - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Oral - Year-over-year growth 2019-2023 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Market share by distribution channel, 2018
Exhibit 33: Market share by geography 2018-2023 (%)
Exhibit 34: Geographic comparison
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Incidence rate of lung cancer
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Key industry trends in North America
Exhibit 41: North America - Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in North America
Exhibit 43: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 44: Incidence rate of cancer in Germany, 2012
Exhibit 45: Projected incidence rate of cancer in Germany, 2030
Exhibit 46: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 47: Top 3 countries in Europe
Exhibit 48: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 49: Facts about cancer in Australia
Exhibit 50: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 51: Top 3 countries in ROW
Exhibit 52: Key leading countries
Exhibit 53: Market opportunity
Exhibit 54: Cancer prevalence in US in 2015
Exhibit 55: Cancer prevalence in England in 2016
Exhibit 56: Types of external beam radiation therapy
Exhibit 57: Impact of drivers and challenges
Exhibit 58: CDC statistics for obesity and diabetes
Exhibit 59: Vendor landscape
Exhibit 60: Landscape disruption
Exhibit 61: Vendors covered
Exhibit 62: Vendor classification
Exhibit 63: Market positioning of vendors
Exhibit 64: M - Vendor overview
Exhibit 65: M - Business segments
Exhibit 66: M - Organizational developments
Exhibit 67: M - Geographic focus
Exhibit 68: M - Segment focus
Exhibit 69: M - Key offerings
Exhibit 70: M - Key customers
Exhibit 71: Acelity LP Inc. - Vendor overview
Exhibit 72: Acelity LP Inc. - Organizational developments
Exhibit 73: Acelity LP Inc. - Key offerings
Exhibit 74: Acelity LP Inc. - Key customers
Exhibit 75: ConvaTec Group Plc - Vendor overview
Exhibit 76: ConvaTec Group Plc - Product segments
Exhibit 77: ConvaTec Group Plc - Organizational developments
Exhibit 78: ConvaTec Group Plc - Geographic focus
Exhibit 79: ConvaTec Group Plc - Segment focus
Exhibit 80: ConvaTec Group Plc - Key offerings
Exhibit 81: ConvaTec Group Plc - Key customers
Exhibit 82: Mölnlycke Health Care AB - Vendor overview
Exhibit 83: Mölnlycke Health Care AB - Product segments
Exhibit 84: Mölnlycke Health Care AB - Organizational developments
Exhibit 85: Mölnlycke Health Care AB - Geographic focus
Exhibit 86: Mölnlycke Health Care AB - Segment focus
Exhibit 87: Mölnlycke Health Care AB - Key offerings
Exhibit 88: Mölnlycke Health Care AB - Key customers
Exhibit 89: Smith & Nephew Plc - Vendor overview
Exhibit 90: Smith & Nephew Plc - Business segments
Exhibit 91: Smith & Nephew Plc - Organizational developments
Exhibit 92: Smith & Nephew Plc - Geographic focus
Exhibit 93: Smith & Nephew Plc - Segment focus
Exhibit 94: Smith & Nephew Plc - Key offerings
Exhibit 95: Smith & Nephew Plc - Key customers
Exhibit 96: Validation techniques employed for market sizing
Exhibit 97: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- 3M
- Acelity LP Inc.
- ConvaTec Group Plc
- Mölnlycke Health Care AB
- Smith & Nephew Plc.
- MORE
Global Radiodermatitis Treatment Market 2019-2023
The analyst recognizes the following companies as the key players in the global radiodermatitis treatment market: 3M, Acelity LP Inc., ConvaTec Group Plc, Mölnlycke Health Care AB, and Smith & Nephew Plc.
Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the increasing focus on new product development.”
According to the report, one of the major drivers for this market is the rising initiatives by research institutes.
Further, the report states that one of the major factors hindering the growth of this market is the increased risk of drug failure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global radiodermatitis treatment market: 3M, Acelity LP Inc., ConvaTec Group Plc, Mölnlycke Health Care AB, and Smith & Nephew Plc.
Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the increasing focus on new product development.”
According to the report, one of the major drivers for this market is the rising initiatives by research institutes.
Further, the report states that one of the major factors hindering the growth of this market is the increased risk of drug failure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- 3M
- Acelity LP Inc.
- ConvaTec Group Plc
- Mölnlycke Health Care AB
- Smith & Nephew Plc.
Note: Product cover images may vary from those shown
